TITLE

Research Capsules

PUB. DATE
November 2008
SOURCE
Pharmaceutical Representative;Nov2008, Vol. 38 Issue 11, p11
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents a study conducted by the researchers of Massachusetts General Hospital concerning the significance of treatment combination to the patients with Alzheimer's disease. Study shows that patients who take a combination of two anti-Alzheimer's disease-medication will be experiencing slower progression of symptom than those who are taking one or no medication.
ACCESSION #
35043735

 

Related Articles

  • ExonHit Attacking Alzheimer's in Therapeutic, Diagnostics. Etheridge, James // BioWorld International;7/9/2008, Vol. 13 Issue 28, p3 

    The article presents an update on the therapeutic and diagnostic approaches for the treatment of Alzheimer's disease by ExonHit Therapeutics SA as of July 9, 2008. These therapeutic approaches involve the EHT 0202 based on a mechanism of action that redirects the processing of the amyloid...

  • Memantine: A Review of its Use in Alzheimer's Disease. Robinson, Dean M.; Keating, Gillian M. // Drugs;2006, Vol. 66 Issue 11, p1515 

    Memantine (Ebixa®, Axura®, Namenda®, Akatinol®) is a moderate-affinity, uncompetitive, voltage-dependent, NMDA-receptor antagonist with fast on/off kinetics that inhibits excessive calcium influx induced by chronic overstimulation of the NMDA receptor. Memantine is approved in the US...

  • Dementia: biological solution still a long way off. Besson, John // British Medical Journal (Clinical Research Edition);10/1/1983, Vol. 287 Issue 6397, p926 

    Discusses the biological solution of the senile dementia of alzheimer type in Great Britain. Abnormalities on the cholinergic system of patients with senile dementia; Complexity implied by the biological findings; Causes of secondary changes in cortical neurons.

  • Screening for acetylcholinesterase inhibitory activity of methanolic extract of Cassia fistula roots. Rajasree, P. H.; Singh, Ranjit; Sankar, C. // International Journal of Pharmacy & Life Sciences;Sep2012, Vol. 3 Issue 9, p1976 

    Inhibition of acetylcholinesterase (AChE), the key enzyme in the breakdown of acetylcholine, is considered as a promising strategy for the treatment of neurological disorders such as Alzheimer's disease, senile dementia, ataxia and myasthenia gravis. Alzheimer's disease (AD) is the most common...

  • Drug for Alzheimer's disease is of little benefit,study shows. Singh, Debashis // BMJ: British Medical Journal (International Edition);7/3/2004, Vol. 329 Issue 7456, p9 

    Reports on a study showing that donepezil, a cholinesterase inhibitor for the treatment of Alzheimer's disease, is of little benefit. Reference to a study published in a 2004 issue of the "Lancet"; Lack of effect on the mental state and functional ability of patients who took the drug; Claim...

  • Oral Drug May Improve Cognition and Function in Patients With Alzheimer's Disease.  // Neurology Reviews;Sep2015, Vol. 23 Issue 9, p11 

    The article discusses a phase 2b trial where 684 patients with mild-to-moderate Alzheimer's disease on a background of stable donepezil therapy were randomized. The patients aged between 50 and 80 with a clinical diagnosis of possible Alzheimer's disease were randomized to placebo or to 15- or...

  • CAN WE PREDICT THE RESPONSE TO GALANTAMINE IN ALZHEIMER`S DISEASE PATIENTS? Gavan, Carmen; Tiu, Cristina; Bajenaru, Ovidiu Alexandru // Romanian Journal of Neurology;2015, Vol. 14 Issue 3, p134 

    Although considerate progress was obtained by adding imagistic and laboratory test, clinical examination remains the core of the diagnosis for Alzheimer`s disease. After 20 years of experience with anticholinergic drugs we know that only one third of the patients respond to the treatment; the...

  • Alzheimer's Unlocked. Park, Alice // Time International (South Pacific Edition);10/25/2010, Vol. 176 Issue 17, p30 

    The article looks at methods used to prevent and treat Alzheimer's disease. Advances in Alzheimer's research are reviewed, including medical evidence that suggests the disease is caused by a buildup of protein-based plaques in the brain and technology that can scan the brain to detect early...

  • Alzheimer's Unlocked. Park, Alice // Time International (Atlantic Edition);10/25/2010, Vol. 176 Issue 17, p30 

    The article looks at methods used to prevent and treat Alzheimer's disease. Advances in Alzheimer's research are reviewed, including medical evidence that suggests the disease is caused by a buildup of protein-based plaques in the brain and technology that can scan the brain to detect early...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics